




To the Editor: Buruli ulcer (BU), 
caused by Mycobacterium ulcerans, is 
one of 13 recently classiﬁ  ed neglected 
tropical diseases (1). Little is known 
about factors inﬂ  uencing its focal dis-
tribution. In Benin, altitude may play a 
role in such distribution of BU.
Incidence, prevalence, and other 
health-related data are usually report-
ed at national or district levels. These 
data convey the importance of the dis-
ease but do not show the wide varia-
tions existing at the village level. Data 
from the surveillance system (2) and 
surveys (3–6) in Benin have shown 
that BU-endemic areas are conﬁ  ned to 
the southern regions. Substantial vari-
ability in endemicity levels have been 
detected from 1 department to another, 
at the district and village levels, and 
from year to year (2–5).
However, some districts (Lalo in 
the Mono-Couffo Department, Ouinhi 
in the Zou Department; Zê in the At-
lantique Department; and Adjohoun, 
Bonou, and Dangbo in the Oueme De-
partment) remain the most persistently 
BU-endemic from year to year. In ad-
dition, these BU-endemic districts are 
all located at the same latitude. A map 
of these districts can be superimposed 
on the Lama depression (a median 
band, oriented from west to east, that 
forms a large area at a low elevation, 
130 km long with a width from 5 km 
in the area of Tchi in Lalo to 25 km 
in the area of Issaba in Pobê) (7). 
This factor prompted us to investigate 
whether variations in altitude correlate 
with BU prevalence.
Using a Garmin eTrex global po-
sitioning system (Olathe, KS, USA), 
we collected precise geographic coor-
dinates, including altitude, for each vil-
lage in 2 persistently BU-endemic dis-
tricts of the Atlantique Department. We 
chose districts where BU endemicity 
was high (Zê) and low (Toffo) (preva-
lences 52.0 and 7.8/10,000 inhabitants, 
respectively) (3,5). On the basis of rou-
tine data collected during 2005–2009, 
we calculated the prevalence of BU in 
each village of these districts and corre-
lated it with the altitude of the village, 
ﬁ   rst by mapping with Healthmapper 
4.3.2 (http://healthmapper.software.
informer.com) and then with statistical 
analyses by using Epi Info 3.5.1 (Cen-
ters for Disease Control and Preven-
tion, Atlanta. GA, USA).
We found that highly BU-endemic 
villages are located most often in low-
land areas (online Appendix Figure; 
www.cdc.gov/EID/content/17/1/153-
appF.htm). The mean prevalence of 
BU was 60.7/10,000 inhabitants in 
villages with elevations <50 m, which 
was signiﬁ  cantly higher than the prev-
alence in villages with elevations 50–
100 meters (10.2/10,000 inhabitants) 
and that of villages with elevations 
>100 meters (5.4/10,000 inhabitants) 
(p = 0.0003; Kruskal-Wallis test).
In addition, we performed a sim-
ple linear regression, including all vil-
lages (model A) and only BU-endemic 
villages (prevalence ≠ 0) (model B). 
Model A showed that at 0 altitude, 
the expected prevalence of BU was 
26.7/10,000 inhabitants. This preva-
lence decreased by 0.1/10,000 inhab-
itants for each meter of increase in 
altitude (correlation coefﬁ  cient  0.20; 
coefﬁ  cient of determination 4%). Mod-
el B demonstrated that at 0 altitude, the 
expected prevalence was 89.6/10,000 
inhabitants. This prevalence decreased 
by 0.7/10,000 inhabitants for each me-
ter of increase in altitude (correlation 
coefﬁ  cient 0.50; coefﬁ  cient of deter-
mination 25%). Therefore, we con-
clude that a low but signiﬁ  cant linear 
relationship exists between altitude 
and BU prevalence in disease-endemic 
villages. Thus, altitude may be 1 factor 
in determining variations in prevalence 
(4% for all villages and 25% for BU-
endemic villages).
The focal distribution of BU was 
discussed in 1974 by Meyers et al. in 
Zaire (8). In the Bas-Congo Province, 
although the concentration of BU in 
Songololo was high, the nearby broad 
Bangu plateau, ≈300 meters higher 
than Songololo, was devoid of BU 
(D.M. Phanzu, unpub. data). Soil and 
geologic features (e.g., chemical com-
position of substrata; vegetation, fauna, 
and pH of swamps) were raised as en-
vironmental factors that might explain 
this focal distribution (8,9). The focal 
distribution of BU was also described 
by Johnson et al., who found an inverse 
relationship between the prevalence of 
the disease in Lalo District villages and 
distance from the Couffo River (4).
Few studies have investigated 
environmental risk factors (other than 
water-related) possibly related to the 
prevalence of BU. In 2008, Wagner et 
al. suggested that villages with higher 
prevalence rates were located in areas 
of low elevation. They associated the 
high prevalence of BU with farming 
activities that occurred primarily at 
low elevations (10). Our results are 
similar, but we have provided addi-
tional quantiﬁ   cation of the relation-
ship between prevalence and altitude.
One reasonable explanation for 
the relationship between altitude and 
BU prevalence is that because low-
lands tend to be wetter than higher 
grounds, they provide more favorable 
conditions for the proliferation and 
spread of the etiologic agent. Further-
more, persons are more apt to frequent 
these wetter lowlands to plant and tend 
their crops, thus becoming vulnerable 
to infectious agents in the area.
An extension of this study to all 
BU-endemic villages is needed to fur-
ther reﬁ  ne our results. The endemicity 
of BU is multifactorial; however, our 
results suggest that altitude should be 
included in future analytical models 
of environmental risk factors for this 
disease.
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Vibrio cholerae O1 
in 2 Coastal 
Villages, Papua 
New Guinea 
To the Editor: Cholera outbreak 
reports are of international public 
health interest, especially in areas that 
were previously cholera free (1). Al-
though many recent cholera outbreaks 
have originated in coastal areas (2), 
identifying the source of cholera in-
troduction has been challenging (1). 
The detection of Vibrio c holerae in 
coastal, brackish and riverine waters 
in cholera-endemic and cholera-free 
areas supports the view that autoch-
tonous V. cholerae is involved in the 
introduction of cholera (3,4). To our 
knowledge, cholera has not been re-
ported in Papua New Guinea, despite 
social and environmental conditions 
likely to facilitate transmission and the 
nation's close proximity to cholera-en-
demic countries (5,6).
On August 6, 2009, a physician 
who visited the coastal village of 
Lambutina reported an outbreak of 
acute watery diarrhea that was associ-
ated with the death of his father and 4 
other persons from this and a neigh-
boring village. The outbreak began in 
the village of Nambariwa and spread 
to neighboring Lambutina, Morobe 
Province. From August 13, multidis-
ciplinary teams worked with the com-
munity to reduce the number of deaths 
through early identiﬁ  cation and treat-
ment of case-patients. The teams also 
worked to limit transmission through 
improvements to the water and sanita-
tion infrastructure and by encouraging 
better hygiene practices among the 
villagers. A suspected case of cholera 
was deﬁ  ned as acute watery diarrhea 
or vomiting in a resident of Lambutina 
or Nambariwa villages since July 22, 
2009. In the 2 villages, 77 cases were 
identiﬁ   ed; attack rates were 14% in 
Lambutina (48/343) and 5.5% in Nam-
bariwa (29/532). The overall case-fa-
tality ratio was 6.5% (5/77); 2 patients 
died after they were discharged from 
the referral hospital.
A retrospective frequency-
matched case–control study was con-
ducted in Lambutina to identify the 
risk factors associated with suspected 
cholera. Neighborhood controls (± 5 
years of age) were selected from un-
affected households. Univariate and 
multivariate analyses were conducted 
with STATA version 10 (StataCorp., 
College Station, TX, USA).
Of the 48 case-patients in Lambu-
tina, 43 participated in the study with 
43 age-matched controls. In addition 
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